Veeva Summit Europe: future-proofed AI set to bolster commercial pharma operations

At the 2025 Veeva Commercial Summit Europe, AI and its relation successful pharma and the wider beingness sciences manufacture was the taxable connected everybody’s lips.

During the conference, executives gathered to sermon the latest developments successful the evolving AI scenery – including professionals from crossed the pharma commercial, integer and selling landscapes.

Attendees and speakers expressed their excitement for the uptake and improvement of AI connected some the short-term and semipermanent scale.

Since its swift emergence to notoriety, AI’s complexity and imaginable has rapidly expanded, resulting successful companies from each country of the beingness sciences manufacture implementing the exertion into their workflow to thrust efficiency.

However, arsenic AI becomes a mainstay tool, speakers astatine the Veeva acme stressed that decision-makers indispensable fig retired the champion usage cases for the exertion connected a day-to-day basis. They were besides definite to admit AI’s existent pitfalls, which became an important talking constituent arsenic manufacture members look to guarantee trust, accuracy and future-proofing are astatine the forefront of the AI revolution.

While AI has made its mode into the operations of astir each concern successful the pharma industry, the exertion is perpetually evolving – meaning it tin instrumentality galore forms wrong a company’s regular workflow.

The latest signifier to drawback the oculus of the assemblage is agentic AI. The caller exertion has been causing rather the disturbance arsenic of late, owed to its capableness to autonomously transportation retired tasks without the request for quality intervention.

In speech with Pharmaceutical Technology, Stefan Schmidt, integer capableness pb of tract engagement astatine Bayer, noted that successful the coming years, agentic AI volition apt trim manual workload for administrative tasks that presently inactive person to beryllium conducted by a unit member.

However, Schmidt stated that Bayer is “not rather there,” with agentic AI – meaning helium is looking to travel the AI adoption travel successful steps.

“I would similar to absorption connected augmented AI earlier moving connected to agentic, arsenic giving autonomy to this exertion truly requires afloat spot successful it,” helium said.

To get the astir retired of agentic AI successful a beingness sciences context, Philipp Luik, VP of European commercialized strategy astatine Veeva, noted that the exertion indispensable beryllium “deeply embedded” into the day-to-day workflow successful a keynote league from the archetypal day.

According to Luik, this means that layering AI workflows is nary longer sufficient, and that exertion indispensable beryllium integrated comprehensively into mundane activities. He besides stated that AI systems should beryllium future-proofed to support up with the exponential improvement the exertion is experiencing.